With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Sofosbuvir + daclatasvir demonstrates high cure rates for people with HIV and HCV co-infection
US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy
Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C
